Antibodies - 2/9

Entry	Author	Date	Location
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s	Luke Timmerman	12/05/10	Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News	Luke Timmerman	11/18/10	Seattle
Montgomery Joins Alder Board	Luke Timmerman	11/01/10	Seattle
PacBio’s $200M IPO, Ablexis’ 5-Way Big Pharma Deal, Codexis Morphs Into $100M Business, & More Bay Area Life Sciences News	Luke Timmerman	10/29/10	San Francisco
Ablexis Cuts Deal With Pfizer, Four Other Pharmas, For Antibody Drug Discovery Tool	Luke Timmerman	10/26/10	San Francisco
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News	Erin Kutz	10/22/10	Boston
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News	Luke Timmerman	10/15/10	San Francisco
ImmunoGen Gets $45M Upfront From Novartis To Make Souped Up Antibodies For Cancer	Luke Timmerman	10/11/10	Boston
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer	Luke Timmerman	10/11/10	Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News	Luke Timmerman	09/30/10	Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer	Luke Timmerman	09/27/10	Seattle
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News	Luke Timmerman	09/24/10	San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies	Luke Timmerman	09/23/10	San Francisco
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond	Luke Timmerman	09/15/10	National
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA	Erin Kutz	08/27/10	Boston
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader	Luke Timmerman	08/17/10	San Francisco
Genentech Agrees to Pay Seattle Genetics Up to $900M for “Empowered Antibodies”	Luke Timmerman	08/03/10	Seattle
ThredUP Funded by New Micro VC Firm, Visterra Grabs $6M, Vivox Gets $2M From Peacock Equity, & More Boston-Area Deals News	Erin Kutz	07/14/10	Boston
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs	Luke Timmerman	07/13/10	San Diego
AnaptysBio Gets $1.5M from DARPA	Bruce V. Bigelow	07/12/10	San Diego
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News	Erin Kutz	07/09/10	Boston
CMC Icos Mounts Comeback, Resumes Hiring, After Pausing During the Downturn	Luke Timmerman	07/07/10	Seattle
Ablexis Maps Out New Antibody Drug Strategy with $12M From Third Rock, Pfizer	Luke Timmerman	06/23/10	San Francisco
Seattle Genetics’ Dark Horse Drug Candidate Approaches Home Stretch in Leukemia Study	Luke Timmerman	06/22/10	Seattle
Theraclone Sciences CEO David Fanning Dies Suddenly	Luke Timmerman	06/14/10	Seattle
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round	Ryan McBride	05/27/10	Boston
Signature Genomic Gets Sold for $90M, DreamBox Bought by Netflix CEO, The $7M Madrona Man, & More Seattle-Area Deals News	Gregory T. Huang	04/21/10	Seattle
The Hybritech Alumni: Where Are They Now?	Luke Timmerman	03/12/10	San Diego
Seattle Genetics Gets Roche Cash	Luke Timmerman	03/03/10	Seattle
Celldex CEO Treks From NJ to Massachusetts in Pursuit of Antibody Drugs for Cancer	Luke Timmerman	02/23/10	Boston
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s

Luke Timmerman

12/05/10

Seattle

Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News

Luke Timmerman

11/18/10

Seattle